Compare Davita Inc (DVA) vs Las Vegas Sands Corp. (LVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs Las Vegas Sands Corp. — how do they compare? Davita Inc trades at $175.04 (market cap $11.28B), while Las Vegas Sands Corp. trades at $36.3 (market cap $23.19B). The key difference: Las Vegas Sands Corp. is far larger — about 2.1× Davita Inc's market cap, and Las Vegas Sands Corp. pays a 3.35% dividend while Davita Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 113 Days and Las Vegas Sands Corp. for 72 Days on average.
| DVA | LVS | |
|---|---|---|
Market Cap | $11.28B | $23.19B |
Volume | 650,294 | 4,822,073 |
Sector | Health | Consumer Cyclical |
52-Week High | $240.96 | $69.49 |
52-Week Low | $103.87 | $35.81 |
Typical Hold Time | 113 Days | 72 Days |
Enterprise Value | $24.00B | $35.08B |
Dividend Yield | — | 3.35% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $177.02, down 1.87% on the day, showing mixed technical signals with a bearish moving average trend but neutral oscillators. Fundamentally, the company demonstrates strong earnings beats with Q2 2026 EPS of $4.02 exceeding expectations of $3.88, while revenue growth continues from $13.64B in 2025 to projected $14.0B in 2026. Recent developments include expanding value-based care partnerships with Humana, potentially benefiting over 10,000 Medicare Advantage members.
The outlook remains cautiously optimistic with 43% analyst buy ratings and a $235.67 consensus price target suggesting 33% upside. However, rising debt-to-asset ratios (65.55% in 2025) and margin pressures from Q2 2026 create headwinds. Key risks include regulatory changes in healthcare reimbursement and competitive pressures in dialysis services.
LVS trades at $36.10, down 0.58% on the day, with a bearish technical signal despite recent earnings beats. The company shows strong revenue growth from $13.02B in 2025 to projected $13.7B in 2026, with consistent profitability margins around 12.5%. Recent news highlights Sands China's community initiatives and environmental certifications, supporting long-term positioning in Macao's tourism market.
Wall Street maintains strong bullish sentiment with 59% buy ratings and a $59.78 price target representing 66% upside potential. Key risks include high debt levels (73.15% debt-to-asset ratio) and Macao regulatory exposure. The current valuation at 13.88 P/E appears attractive relative to growth prospects, though technical indicators suggest near-term pressure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About Las Vegas Sands Corp.
Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner, Four Seasons Hotel Macao, and Parisian in Macao, and the Marina Bay Sands resort in Singapore. Its Venetian and Palazzo Las Vegas in the U.S. asets were sold to Apollo and VICI for $6.25 billion in 2022. We expect Sands to open a fourth tower in Singapore in 2026. After the sale of its Vegas assets, the company will generate all its EBITDA from Asia, with its casino operations generating the majority of sales.
Read more on LVS →
